Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (10746)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Oct 24, 2021 (publication date) through Nov 21, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Oncology
ISSN
2218-4333
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| Saito A, Yoshida H, Nishikawa T, Yonemori K. Human epidermal growth factor receptor 2 targeted therapy in endometrial cancer: Clinical and pathological perspectives. World J Clin Oncol 2021; 12(10): 868-881 [PMID: 34733610 DOI: 10.5306/wjco.v12.i10.868] |
|
|
|
| ©2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA | |
| For: | Saito A, Yoshida H, Nishikawa T, Yonemori K. Human epidermal growth factor receptor 2 targeted therapy in endometrial cancer: Clinical and pathological perspectives. World J Clin Oncol 2021; 12(10): 868-881 [PMID: 34733610 DOI: 10.5306/wjco.v12.i10.868] |
|---|---|
| URL: | https://www.wjgnet.com/2218-4333/full/v12/i10/868.htm |
| Number | Citing Articles |
| 1 |
Takuya Yoshimura, Shotaro Higashi, Sohsuke Yamada, Hirotsugu Noguchi, Mitsuharu Nomoto, Hajime Suzuki, Takayuki Ishida, Hirotaka Takayama, Yuka Hirano, Masaru Yamashita, Akihide Tanimoto, Norifumi Nakamura. PCP4/PEP19 and HER2 Are Novel Prognostic Markers in Mucoepidermoid Carcinoma of the Salivary Gland. Cancers 2021; 14(1): 54 doi: 10.3390/cancers14010054
|
| 2 |
Nora Diéguez-Martínez, Sergio Espinosa-Gil, Guillermo Yoldi, Elisabet Megías-Roda, Idoia Bolinaga-Ayala, Maria Viñas-Casas, Gokhan Gorgisen, Inés Domingo-Ortí, Héctor Pérez-Montoyo, Jose R. Bayascas, Eva Colas, Xavier Dolcet, Jose M. Lizcano. The ERK5/NF-κB signaling pathway targets endometrial cancer proliferation and survival. Cellular and Molecular Life Sciences 2022; 79(10) doi: 10.1007/s00018-022-04541-6
|
| 3 |
S. Koppikar, A. Oaknin, K. Govind Babu, D. Lorusso, S. Gupta, L.-Y. Wu, W. Rajabto, K. Harano, S.-H. Hong, R.A. Malik, H. Strebel, I.M. Aggarwal, C.-H. Lai, T. Dejthevaporn, S. Tangjitgamol, W.F. Cheng, W.Y. Chay, D. Benavides, N.M. Hashim, Y.W. Moon, M. Yunokawa, T.D. Anggraeni, W. Wei, G. Curigliano, A. Maheshwari, U. Mahantshetty, S. Sheshadri, S. Peters, T. Yoshino, G. Pentheroudakis. Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with endometrial cancer. ESMO Open 2023; 8(1): 100774 doi: 10.1016/j.esmoop.2022.100774
|
| 4 |
Yi-Kai Fu, Ching-Yu Shih, Chiao-Yin Cheng, Hua Ho, Yen-Lin Chen. HOXA5 as a Dual Modulator of Tumor Biology in Endometrial Cancer. Cancers 2025; 17(15): 2473 doi: 10.3390/cancers17152473
|
| 5 |
Turgut Keles, Gökçe Seyhan, Zekeriya Biyiklioglu, Kübra Kolci, Rengin Reis, Burak Barut. Dendritic, Water‐Soluble, and Nonaggregated Axially Substituted Silicon Phthalocyanine as Potential Endometrial Anticancer Agent. Applied Organometallic Chemistry 2024; 38(12) doi: 10.1002/aoc.7699
|
| 6 |
Nooshafarin Shirani, Neda Abdi, Matin Chehelgerdi, Hajar Yaghoobi, Mohammad Chehelgerdi. Investigating the role of exosomal long non-coding RNAs in drug resistance within female reproductive system cancers. Frontiers in Cell and Developmental Biology 2025; 13 doi: 10.3389/fcell.2025.1485422
|
| 7 |
Yidong Ge, Xiaoqi Ni, Jingyun Li, Meng Ye, Xiaofeng Jin. Roles of estrogen receptor α in endometrial carcinoma (Review). Oncology Letters 2023; 26(6) doi: 10.3892/ol.2023.14117
|
| 8 |
Noura A A Ebrahim, Tamer S Eissa, Mustafa A Hussein, Omnia Mohamed Korany, Nancy H Amin. Tight junction disruption <i>via</i> claudin-6 overexpression promotes invasion and recurrence in high-grade endometrial tumors. World Journal of Clinical Oncology 2025; 16(11): 110257 doi: 10.5306/wjco.v16.i11.110257
|
| 9 |
Kyoko Oura, Asahiro Morishita, Mai Nakahara, Tomoko Tadokoro, Koji Fujita, Joji Tani, Tsutomu Masaki, Hideki Kobara. Chronic Liver Disease Associated Cholangiocarcinoma: Genomic Insights and Precision Therapeutic Strategies. Cancers 2025; 17(18): 3052 doi: 10.3390/cancers17183052
|
| 10 |
Malames M. Faisal, Marwa M. Shakweer, Ghada Refaat, Khaled S. Mohammed, Tarek I. ElMallawy, Magda H. Nasreldin, Laila M. Farid, Mariam B. Abouelkhair. Analysis of human epidermal growth factor receptor 2 immunohistochemical expression in high-grade endometrial carcinomas and its association with variable clinical outcomes. Egyptian Journal of Pathology 2023; 43(2): 119 doi: 10.4103/egjp.egjp_27_23
|
| 11 |
Jean-Christophe Currie, Michel Demeule, Cyndia Charfi, Alain Zgheib, Alain Larocque, Bogdan Alexandru Danalache, Amira Ouanouki, Richard Béliveau, Christian Marsolais, Borhane Annabi. The Peptide-Drug Conjugate TH1902: A New Sortilin Receptor-Mediated Cancer Therapeutic against Ovarian and Endometrial Cancers. Cancers 2022; 14(8): 1877 doi: 10.3390/cancers14081877
|
| 12 |
Bradley Corr, Casey Cosgrove, Daniel Spinosa, Saketh Guntupalli. Endometrial cancer: molecular classification and future treatments. BMJ Medicine 2022; 1(1): e000152 doi: 10.1136/bmjmed-2022-000152
|
| 13 |
Hiroshi Yoshida, Chiharu Mizoguchi, Ayumi Saito, Rui Kitadai, Kasumi Yamamoto, Tadaaki Nishikawa, Tomoyasu Kato, Kan Yonemori. Discordances in expression of human epidermal growth factor receptor 2 between primary and metastatic uterine carcinosarcoma: A proposal for HER2-targeted therapy specimen selection. Annals of Diagnostic Pathology 2023; 65: 152150 doi: 10.1016/j.anndiagpath.2023.152150
|
| 14 |
Victoria E. Rodriguez, Miles Morrow, Rajeshree Rajpara, Dana M. Chase. Endometrial cancer therapy in 2026. Current Opinion in Obstetrics & Gynecology 2025; doi: 10.1097/GCO.0000000000001078
|